InvestorsHub Logo
Followers 3
Posts 964
Boards Moderated 0
Alias Born 03/30/2021

Re: TexasMarvL post# 5158

Friday, 03/29/2024 9:30:08 AM

Friday, March 29, 2024 9:30:08 AM

Post# of 5329
Versea Health hired Stephen Gizzi as a regional sales manager for the New York metro area 5 months ago.

Yesterday Verséa Ophthalmics added a new paying customer from New York. Funny how that works.

Verséa Ophthalmics and Verséa Health are building a sales staff that has added new customers from New York to Seattle. From Cincinnati to Miami. Don't forget about the new customers in Colorado, Oklahoma, Texas, Georgia, and Missouri.

Most of these new sales managers have been in the EyeCare space for many years and already have customers they have built relationships with over the years.

In my opinion, if you want to build a brand new company from the ground up, you probably want to have qualified sales people in all of the major metro areas where your customers live and are doing business. Sure it seems slow right now adding just one customer per week. But just step back and look at where all of these new customers live. Verséa Ophthalmics is adding new customers from every region in the country.

My memory fails me right now.
I don't remember any customers from Los Angeles or Phoenix. A parent company was based in Dallas.

I think AXIM was very successful in choosing Verséa Ophthalmics to sell our Diagnostics tests.

Good luck to all.
Not investment advice.
Don't invest money needed for food or rent or happiness.

Hashtags related to our company and partners.

Merchandising partner:
#VerséaOphthalmics
#VerséaHealth
#TPOC Tear based Point-of-Care
#DryEye #Diagnostics #Quantitative
#Lactoferrin #TotalIgE
#TPOCTITAN #TPOCTITANS

Manufacturing Partner:
#AuerPrecision ISO Certified
#ISO9001 #ISO13485

#AXIMBIOTECH
#AXIMEYE #DryEye
#Parkinsons #TPOC #Diagnostics
#Lactoferrin #510K
510(k) Number K934473
#TotalIgE #510K
510(k) Number. K991316
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXIM News